Teledyne FLIR Announces ION M640x Next-Gen Tactical Quadcopter
11.10.2021 14:01:00 EEST | Business Wire | Press release
Teledyne FLIR, part of Teledyne Technologies Incorporated (NYSE:TDY), today announced the launch of the ION™ M640x tactical Unmanned Aerial System (UAS). The American designed, developed, and manufactured UAS builds on the capabilities of the ION M440 (a Blue sUAS) and will provide military and other government customers with best-in-class capabilities for their unique missions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211011005025/en/
The Teledyne FLIR ION™ M640x tactical Unmanned Aerial System (UAS) is an American designed, developed, and manufactured UAS that will provide military and public safety users with best-in-class capabilities for their missions. The ION M640x features a 640x512 infrared sensor providing twice the resolution of similar UAS, and a Near-Infrared (NIR) laser illuminator. ION M640x includes all-new smart object tracking that enables operators to designate an object for the aircraft to detect and track while it moves. The M640x is MAVLINK compliant and interoperable with Common Ground Control Stations (C-GCS), including the U.S. Army Tactical Open Ground Station Architecture (TOGA). Easily rucksack portable at about 4 pounds, the M640x is rated for operation in demanding environments, including rain and wind. The ION M640x is evolved from the ION M440, one of the original five UAS platforms approved by the U.S. Dept. of Defense under the Blue sUAS program. (Photo: Business Wire)
“Our proven, U.S.-based engineering expertise and focus on defense and public safety markets means our customers are getting the most secure and capable UAS solutions,” said Thomas Rambo, senior director of Unmanned and Integrated Solutions at Teledyne FLIR. “The ION M640x builds on our unique position as a domestic provider of unmanned systems and sensing technology and boasts high resolution infrared imaging, smart object tracking, laser illumination, and industry-leading support and service.”
The ION M640x features a 640x512 infrared sensor providing twice the resolution of similar UAS, and a Near-Infrared (NIR) laser illuminator. The NIR illuminator enables operators to pinpoint objects of interest for increased coordination and visibility for other mission participants. ION M640x also includes all-new smart object tracking that enables operators to designate an object for the aircraft to detect and track while it moves. Other new features include an SD card to easily retrieve photos and video recorded during flight, as well as tri-band radio capabilities.
Open system architecture is another key feature of the ION M640x, and the system utilizes a high-powered discrete mission computer for advanced autonomous functions. It is also MAVLINK compliant and interoperable with Common Ground Control Stations (C-GCS), including the U.S. Army Tactical Open Ground Station Architecture (TOGA). Easily rucksack portable at about 4 pounds, the M640x is rated for operation in demanding environments, including rain and wind.
The ION M640x is evolved from the ION M440, one of the original five UAS platforms approved by the U.S. Department of Defense under the Blue sUAS program, for sale to U.S. military and federal agencies. The M440 was developed by Gainesville, Florida-based Altavian Inc., which FLIR acquired in December 2020.
Leveraging Teledyne FLIR’s longstanding reputation as a trusted provider of unmanned systems for military and public safety organizations, the ION M640x is backed by the company’s world class standards for service, training, and technical support.
About Teledyne FLIR
Teledyne FLIR, a Teledyne Technologies company, is a world leader in intelligent sensing solutions for defense and industrial applications with approximately 4,000 employees worldwide. Founded in 1978, the company creates advanced technologies to help professionals make better, faster decisions that save lives and livelihoods. For more information, please visit www.teledyneflir.com or follow @flir.
About Teledyne Technologies
Teledyne Technologies is a leading provider of sophisticated digital imaging products and software, instrumentation, aerospace and defense electronics, and engineered systems. Teledyne's operations are primarily located in the United States, the United Kingdom, Canada, and Western and Northern Europe. For more information, visit Teledyne's website at www.teledyne.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211011005025/en/
Contact information
Joe Ailinger, Jr.
Teledyne FLIR
Phone: +1 781-801-6161
Email: joe.ailinger@teledyneflir.com
Ryan Williams
Targeted Victory
Phone: +1 617-697-9072
Email: rwilliams@targetedvictory.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom